Advanced in Liver Failure

Aldo J. Loza-Montano

Edmonton, AB, CA 
Advanced in Liver Failure
Edmonton, AB, CA 
OverviewLocationsClinical Research

Overview

Aldo Loza-Montano practices in Edmonton, Canada. Mr. Loza-Montano is rated as an Advanced expert by MediFind in the treatment of Liver Failure. His top areas of expertise are Autoimmune Hepatitis, Cholangitis, Sclerosing Cholangitis, Liver Transplant, and Endoscopy.

His clinical research consists of co-authoring 176 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 16 articles in the study of Liver Failure.

Gender
Male

Locations

Edmonton, AB, Canada
Other Locations
AB, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)
Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)
Enrollment Status: Completed
Publish Date: October 25, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

176 Total Publications

Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis.
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis.
Journal: Alimentary pharmacology & therapeutics
Published: April 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Loza-Montano's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 9 Advanced Conditions
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile